Artelo Biosciences, Inc. announced that it will receive $20,096,972 in funding on May 13, 2022. The company will issue common shares in the transaction. The company will issue securities pursuant to exemption provided under Regulation D.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.33 USD | -0.74% | +2.28% | -5.00% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.00% | 4.29M | |
-2.63% | 102B | |
+1.62% | 96.29B | |
+1.60% | 22.18B | |
-16.67% | 21.2B | |
-8.75% | 18.31B | |
-38.74% | 17.38B | |
-13.21% | 16.36B | |
+5.41% | 13.97B | |
+33.57% | 12.17B |
- Stock Market
- Equities
- ARTL Stock
- News Artelo Biosciences, Inc.
- Artelo Biosciences, Inc. announced a financing transaction